References
- Verstraete AG, Puddu M. Evaluation of different roadside drug tests. In: Verstraete AG, editor. ROSITA. Roadside testing assessment. Ghent: ROSITA Consortium; 2001. p. 167–232.
- Verstraete AG, Raes E, editors. ROSITA-2 project. Final Report. Ghent: ROSITA Consortium; 2006.
- Blencowe T, Pehrsson A, Lillsunde P, Vimpari K, Houwing S, Smink B, Mathijssen R, Van der Linden T, Legrand S, Pil K, Verstraete A. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci Int. 2011;208:173–179.
- Blencowe T, Pehrsson A, Lillsunde P, editors. An evaluation of oral fluid screening devices and preceding selection procedures. DRUID Deliverable D3.2.2. Helsinki: National Institute for Health and Welfare; 2009.
- Desrosiers NA, Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Heustis MA. On-site test for cannabinoids in oral fluid. Clin Chem. 2012;58(10):1418–1425.
- Musshoff F, Hokamp EG, Bott U, Madea B. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany. Forensic Sci Int. 2014;238:120–124.
- Strano-Rossi S, Castrignano E, Anzillotti L, Serpelloni G, Mollica R, Tagliaro F, Pascali JP, di Stefano D, Sgalla R, Chiarotti M. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwip 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis. Forensic Sci. Int. 2012;221:70–76.
- Vanstchelman S, Isalberti C, Van der Linden T, Pil K, Legrand S-A, Verstraete AG. Analytical evaluation of four on-site oral fluid drug testing devices. J Anal Tox. 2012;36:136–140.
- Logan BK, Mohr A, Talpins SK. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices. J Anal Tox. 2014;38:444–450.
- Canadian Centre on Substance Abuse. Administrative sanctions for low blood alcohol concentration drivers. Ottawa: Canadian Centre on Substance Abuse; 2016.